Papers: 10.1128/JVI.01819-20

https://doi.org/10.1128/JVI.01819-20

A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CL ^pro Inhibitor PF-00835231 as a Potential New Treatment for COVID-19

Cited by: 88
Author(s): Maren de Vries, Adil Mohamed, Rachel A Prescott, Ana M. Valero-Jimenez, Ludovic Desvignes, Rebecca E. O’Connor, Claire M. Steppan, Joseph C. Devlin, Ellie Ivanova, Alberto Herrera, Austin Schinlever, Paige Loose, Kelly V. Ruggles, Sergei B. Koralov, Annaliesa S. Anderson, Joseph Binder, Meike Dittmann
Published: over 4 years ago

Software Mentions 2